Proportional odds assumption for modeling longitudinal ordinal multiple toxicity outcomes in dose finding studies of targeted agents: A pooled analysis of 54 studies by Damien Drubay, Laurence Collette, Xavier Paoletti

Get full text

The case against censoring of progression-free survival in cancer clinical trials – A pandemic shutdown as an illustration by Corinne Jamoul, Laurence Collette, Elisabeth Coart, Koenraad D’Hollander, Tomasz Burzykowski, Everardo D. Saad, Marc Buyse

Get full text

Comparison of ⁶⁸Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI)... by Julien Van Damme, Bertrand Tombal, Laurence Collette, Sandy Van Nieuwenhove, Vassiliki Pasoglou, Thomas Gérard, François Jamar, Renaud Lhommel, Frédéric E. Lecouvet

Get full text

Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in Nonseminoma by Christian D. Fankhauser, Abolghassem Jandari, Laurence Collette, Torgrim Tandstad, Di Maria Jiang, Ugo De Giorgi, Christopher Sweeney, Angelika Terbuch, Michal Chovanec, Robert Huddart, Carsten Bokemeyer, Jörg Beyer, Silke Gillessen

Get full text

International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer by Marieke van Leeuwen, Jacobien M. Kieffer, Fabio Efficace, Sophie D. Fosså, Michel Bolla, Laurence Collette, Marc Colombel, Ugo De Giorgi, Bernhard Holzner, Lonneke V. van de Poll-Franse, Hendrik van Poppel, Jeff White, Ronald de Wit, Susanne Osanto, Neil K. Aaronson, for the European Organisation for Research and Treatment of Cancer Quality of Life Group, Genito-Urinary Cancers Group and Radiation Oncology Group, and the NCRN Testis Clinical Studies Group

Get full text